Miguel García-Guzman, Ph.D.

Vertex Pharmaceuticals


Dr. García-Guzman is Associate  Director at Vertex Pharmaceuticals San Diego Laboratories where he leads preclinical programs in the areas of GPCRs and pain drug discovery. Dr. García-Guzman is an expert in the implementation of assays to screen small-molecule libraries. Prior to joining Vertex, Dr. García-Guzman worked at Aurora Biosciences, a biotech company later acquired by Vertex, The Burnham Institute for Medical Research, and the Max-Planck Institute of Göttingen, where he characterized novel ligand-gated ion channels.